Intervention for liver transplant recipients with alcohol use disorder

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial focuses on liver transplantation recipients who have a history of alcohol use disorder. It aims to implement a post-transplant addiction intervention to reduce the risk of alcohol relapse, which can significantly impair long-term survival. The study will involve a transdisciplinary approach, integrating addiction specialists into the liver transplant program to provide comprehensive care. By addressing the behavioral aspects of alcohol use, the trial seeks to improve patient outcomes and survival rates after liver transplantation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 18 years or above
* Hospitalized for LT for AALD as primary, secondary or tertiary indication
* Discharged from intensive care unit to hepatology or surgery wards

Exclusion Criteria:

* Severe alcohol-associated hepatitis as primary indication for liver transplantation
* Impossibility of patient follow up over the next 2 years
* General criteria:

  * Refusal or absence of informed consent,
  * Non-affiliation to the French national health insurance,
  * Persons placed under legal protection, guardianship or curatorship

Where it's running

• Besançon University Hospital
  Besançon, France Recruiting
• Bordeaux University Hospital
  Bordeaux, France Recruiting
• Clermont Ferrand University Hospital
  Clermont-Ferrand, France Recruiting
• Dijon University Hospital
  Dijon, France Recruiting
• Lille University Hospital
  Lille, France Recruiting
• Lyon University Hospital
  Lyon, France Recruiting

Study contacts

• Principal investigator: Hélène DONNADIEU, MD, PhD — University Hospital, Montpellier
• Study coordinator: Hélène DONNADIEU, MD, PhD
• Email: h-donnadieu@chu-montpellier.fr
• Phone: 0467337020

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Everolimus-based calcineurin-free immunosuppression one year after liver transplant

  This trial tests whether switching to or using everolimus with reduced calcineurin inhibitors after year one post-liver transplant can protect kidney function while maintaining graft health in adults at low rejection risk.

  Recruiting Phase 3 Hannover Medical School · Heidelberg, Baden-Wurttemberg and 15 other locations · NCT07739914

• Sleep quality and its determinants during the liver transplant pathway

  This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.

  Recruiting Hospices Civils de Lyon · Lyon · NCT07674355

• Preoperative CIMT and Intraoperative Hemodynamics in Liver Transplant

  This study looks at whether a higher carotid IMT measured before surgery is linked to more unstable blood pressure during liver transplant.

  Recruiting Dicle University · Diyarbakır · NCT07660679

• Reference framework for outcomes after machine-preserved liver transplantation in Europe

  This study tests how liver transplants that use machine perfusion perform in real-world practice, to see how different perfusion methods relate to outcomes for adults in Europe.

  Recruiting at 4 sites University Medical Center Groningen · Innsbruck and 37 other locations · NCT07585890

• Even protein distribution plus exercise for people awaiting liver transplant

  This trial tests whether spreading daily protein evenly and combining it with a 12-week exercise program improves nutrition, muscle mass, and function in people waiting for a liver transplant compared with uneven protein timing or usual advice.

  Recruiting at 2 sites Agricultural University of Athens · Athens, Attica and 1 other locations · NCT07561138

• Integrating medications and brief counseling for alcohol use disorder into hepatology clinics

  This project will test a way to help hepatology clinic clinicians provide medicines and short counseling for people with alcohol use disorder and alcohol-associated liver disease.

  Recruiting Yale University · New Haven, Connecticut · NCT07525258

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.